The efficacy of sclerotherapy as the initial treatment in patients with bleeding from Dieulafoy's lesion of the upper gastrointestinal tract

Qingping Ouyang,Yanhong Xia,Liping Wang,Jiayu Qiu,Yanxia Zhang,Ruiying Ding,Zhenhua Zhu,Xu Shu,Xiaolin Pan
DOI: https://doi.org/10.1007/s00464-024-10854-3
2024-05-26
Surgical Endoscopy
Abstract:Dieulafoy's lesion (DL) is a rare and important cause of acute nonvariceal upper gastrointestinal bleeding (ANVUGIB), however, there is a lack of clear guidelines focus on the endoscopic hemostasis treatment for DL. Sclerotherapy, as the ANVUGIB guideline recommended endoscopic hemostasis method, is widely used in clinical practice. The aim of this study is to investigate the efficacy of sclerotherapy as the initial treatment for Dieulafoy's lesion of the upper gastrointestinal tract (UDL).
surgery
What problem does this paper attempt to address?